82 completed, 16 recruiting, 10 withdrawn, 9 active not recruiting. 39 Not applicable, 39 Phase 2, 8 Phase 1, 6 Phase 3, 1 Early Phase 1.
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer HYPNOSIS - Sarcoma, Germ Cell Tumor of Testis | Not applicable | Recruiting | Institut Bergonié | 70 | 2026-09-15 | 2026-09-22 |
| Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer. Inject of hyaluronic acid in the face - Breast Cancer, Aesthetic Improvement of the Skin | Not applicable | Not yet recruiting | Institut Bergonié | 22 | 2026-04-01 | 2026-04-16 |
| Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma Blood sample - Pancreas Cancer | Recruiting | Institut Bergonié | 50 | 2026-03-27 | 2026-04-20 | |
| MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. MEDI5752 - Advanced Solid Tumor | Phase 2 | Not yet recruiting | Institut Bergonié | 102 | 2025-09-01 | 2025-08-13 |
| STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue Educational content, Educational material plus self-management program - self-administered version, Educational material plus self-management program - guided version with mental health professional - Cancer Diagnosis, Moderate or Severe Score of Cancer-related Fatigue (CRF) | Not applicable | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 372 | 2025-09-01 | 2025-09-15 |
| Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour Doxorubicin, Trabectedin - Leiomyosarcoma Uterus | Phase 2 | Recruiting | UNICANCER | 198 | 2025-01-27 | 2026-09-29 |
| Streamlined Geriatric and Oncological Evaluation Based On IC Technology GERONTE - Breast Cancer, Comorbidities and Coexisting Conditions | Not applicable | Active not recruiting | Institut Bergonié | 720 | 2024-10-15 | 2026-10-13 |
| Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures Ezabenlimab + BI907828 - Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer | Phase 2 | Withdrawn | Institut Bergonié | 2024-06-14 | 2025-09-02 | |
| Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours No intervention - Stump | Recruiting | Institut Bergonié | 392 | 2023-12-01 | 2026-01-15 | |
| Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. Prostate Cancer, Metastasis | Recruiting | Institut Bergonié | 50 | 2023-11-01 | 2026-01-30 | |
| Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer Association of lurbinectedin and durvalumab, Association of carboplatin and etoposide - Small Cell Lung Cancer, Platinum-Sensitive Lung Small Cell Carcinoma | Phase 2 | Withdrawn | Institut Bergonié | 2023-10-01 | 2024-06-05 | |
| Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene PTEN Gene Mutation | Suspended | Institut Bergonié | 430 | 2023-06-12 | 2026-05-15 | |
| Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer Association of darolutamide and EBRT, Association of ADT and EBRT - Prostate Cancer | Phase 2 | Recruiting | Institut Bergonié | 62 | 2023-02-24 | 2026-10-08 |
| Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. Cognitive remediation - Breast Cancer | Not applicable | Active not recruiting | Institut Bergonié | 164 | 2023-02-01 | 2025-08-13 |
| Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) Doxorubicin, Ifosfamide, INCMGA00012 - Resectable Sarcoma | Phase 2 | Active not recruiting | Institut Bergonié | 66 | 2022-12-07 | 2026-10-08 |
| Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA). - Ovarian Carcinoma | Not applicable | Completed | Institut Bergonié | 25 | 2022-06-11 | 2026-10-13 |
| Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas Association of pembrolizumab + cabozantinib - Soft Tissue Sarcoma Adult, Advanced Soft-tissue Sarcoma | Phase 2 | Recruiting | Institut Bergonié | 119 | 2022-04-25 | 2025-10-07 |
| Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma Bintrafusp alfa, Doxorubicin - Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | Phase 2 | Active not recruiting | Institut Bergonié | 80 | 2022-03-01 | 2026-07-24 |
| Targeting ATR in Soft-tissue Sarcomas Association of berzosertib with gemcitabine, Gemcitabine - Leiomyosarcoma, Adult | Phase 2 | Completed | Institut Bergonié | 58 | 2022-02-09 | 2026-05-05 |
| Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients EGFR gene mutation analysis on liquid biopsy - Non Small Cell Lung Cancer, Advanced Solid Tumor | Not applicable | Completed | Institut Bergonié | 581 | 2022-01-01 | 2026-03-06 |
Showing 20 of 130. Sign in to see all of them.
Breast Neoplasms (28) · Sarcoma (24) · Neoplasms (18) · Neoplasm Metastasis (13) · Colorectal Neoplasms (11) · Prostatic Neoplasms (11) · Ovarian Neoplasms (9) · Carcinoma, Non-Small-Cell Lung (8) · Lymphoma (6) · Tertiary Lymphoid Structures (6) · Colonic Neoplasms (5) · Rectal Neoplasms (5) · Lung Neoplasms (4) · Pancreatic Neoplasms (4) · Urinary Bladder Neoplasms (4)
Cyclophosphamide (4) · Doxorubicin (4) · durvalumab (4) · Blood Specimen Collection (3) · Leucovorin (3) · Rituximab (3) · efavirenz (3) · Base Sequence (2) · Cetuximab (2) · Drug Therapy (2) · Fluorouracil (2) · Geriatric Assessment (2) · High-Throughput Nucleotide Sequencing (2) · Ifosfamide (2) · Imatinib Mesylate (2)
France (121) · Austria (1)
Carine Bellera, PhD (3) · Maud Toulmonde, MD (3) · Antoine Italiano, MD/PhD (2) · Florence Dixmerias, MD (2) · Pierre Soubeyran, MD, PhD (2) · Antoine Italiano (1)
PMID 28391775, PMID 31401903, PMID 32713836, PMID 12893206, PMID 15350354, PMID 16875720, PMID 18662417, PMID 18820667, PMID 19189349, PMID 19395008, PMID 20564641, PMID 20609464, PMID 20818904, PMID 21665421, PMID 21907007, PMID 22396054, PMID 22508806, PMID 23122780, PMID 24042540, PMID 24062399, PMID 24285018, PMID 24567518, PMID 24758527, PMID 24814311, PMID 25070543, PMID 25256896, PMID 25355844, PMID 25503576, PMID 25777085, PMID 25837603, PMID 25944225, PMID 26041763, PMID 26171933, PMID 26371288, PMID 26405647, PMID 26467471, PMID 27587597, PMID 27908282, PMID 28280221, PMID 28662235, PMID 29030150, PMID 29117335, PMID 29454321, PMID 29482777, PMID 29635147, PMID 29763754, PMID 29874526, PMID 30143031, PMID 30212804, PMID 30349653
2023 (5), 2019 (3), 2014 (2), 2016 (2), 2018 (2), 2008 (1), 2009 (1), 2015 (1), 2017 (1)